Skip to Main Content

Author Details

Maria Del Pilar Estevez Diz
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
2002
58
17
PMIDPaper TitleJournal TitlePublished Year
38059899Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.JAMA2024
35144717Applying mucosal barrier injury laboratory-confirmed bloodstream infection criteria in patients with solid tumors and hematologic malignancies: A retrospective cohort study looking for the real source of infection.Infect Control Hosp Epidemiol2023
38039991Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.Lancet Oncol2023
37969375Immune checkpoint inhibitors: here to stay.Transl Cancer Res2023
36102415Clinical presentation and in-hospital prognosis of lung cancer patients presenting with suspected and confirmed COVID-19.Braz J Med Biol Res2022
32537695Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer.Appl Health Econ Health Policy2021
33664128Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission.Int J Gynecol Cancer2021
34287479Germline and Somatic mutations in postmenopausal breast cancer patients.Clinics (Sao Paulo)2021
34228508Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19.JCO Glob Oncol2021
33998104Role of systematic pelvic and para-aortic lymphadenectomy in delayed debulking surgery after six neoadjuvant chemotherapy cycles for high-grade serous ovarian carcinoma.J Obstet Gynaecol Res2021
32256980The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis.Oncotarget2020
33027380Cancer and Cardiovascular Diseases during the COVID-19 Pandemic.Arq Bras Cardiol2020
32582375Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries.Ecancermedicalscience2020
32134921Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.PLoS One2020
32321767Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.Int J Gynecol Cancer2020
32294673How should health systems prepare for the evolving COVID-19 pandemic? Reflections from the perspective of a Tertiary Cancer Center.Clinics (Sao Paulo)2020
30974190Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.J Steroid Biochem Mol Biol2019
31939569Integrated care pathway for rectal cancer treatment: cross-sectional post-implementation study using a logic model framework.Sao Paulo Med J2019
30895400Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.Gastric Cancer2019
29670722Stafne's bone defect in a metastatic prostate cancer patient: A diagnostic conundrum.J Clin Exp Dent2018
30241227Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis.J Glob Oncol2018
30133561Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management.Clinics (Sao Paulo)2018
30101142Health Economic Evaluations of Cancer in Brazil: A Systematic Review.Front Public Health2018
29907814The germline mutational landscape of BRCA1 and BRCA2 in Brazil.Sci Rep2018
29854292Somatic mutations in early onset luminal breast cancer.Oncotarget2018
30085844Palliative Care in the Global Setting: ASCO Resource-Stratified Practice Guideline.J Glob Oncol2018
29947654Guidelines for early detection of breast cancer in Brazil. II - New national recommendations, main evidence, and controversies.Cad Saude Publica2018
30517521Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation.Rev Saude Publica2018
28619461Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries.Maturitas2017
28107261Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?Int J Gynecol Cancer2017
28157723Integrated care pathway for rectal cancer treatment: health care resource utilization, costs, and outcomes.Int J Evid Based Healthc2017
28240687Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients: The Transfusion Requirements in Critically Ill Oncologic Patients Randomized Controlled Trial.Crit Care Med2017
28981596Early mobilization programme improves functional capacity after major abdominal cancer surgery: a randomized controlled trial.Br J Anaesth2017
28596804Bringing a humanistic approach to cancer clinical trials.Ecancermedicalscience2017
28595442Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.Ann Palliat Med2017
27137353Carboplatin-based chemoradiotherapy in advanced cervical cancer: an alternative to cisplatin-based regimen?Eur J Obstet Gynecol Reprod Biol2016
28717710Zika Virus in a Patient With Cancer: How Much Do We Know?J Glob Oncol2016
27914478Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.BMC Cancer2016
27192130Hereditary cancer risk assessment: insights and perspectives for the Next-Generation Sequencing era.Genet Mol Biol2016
25169967Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.Eur J Clin Microbiol Infect Dis2015
26248245Association of family risk and lifestyle/comorbidities in ovarian cancer patients.Rev Assoc Med Bras (1992)2015
26182837Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?Eur J Obstet Gynecol Reprod Biol2015
25968072Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.Oncology2015
26026738A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma.Gynecol Oncol2015
25401417Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial.Anesthesiology2015
24333355Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.Gynecol Oncol2014
28573118Advanced small-cell ovarian carcinoma, hypercalcemic type: a challenging therapeutic entity.Autops Case Rep2014
25506007Late isolated central nervous system relapse from ovarian serous adenocarcinoma: a case report and literature review.Case Rep Obstet Gynecol2014
25276328Immature uterine teratoma associated with uterine inversion.Rare Tumors2014
24503812Laparoscopic extrafascial hysterectomy (completion surgery) after primary chemoradiation in patients with locally advanced cervical cancer: technical aspects and operative outcomes.Int J Gynecol Cancer2014
  • 1 - 50 of 58

Recommended Authors

George Au-Yeung
The University of Melbourne
Career Start Year 2012
Number of shared co-authors 0
Eloise Chapman-Davis
Weill Cornell Medical College
Career Start Year 2009
Number of shared co-authors 0
Yovanni Casablanca
Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
Career Start Year 2007
Number of shared co-authors 0
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Susana Banerjee
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 2005
Number of shared co-authors 1
Stefan Kommoss
Eberhard Karls University Tubingen
Career Start Year 2005
Number of shared co-authors 0
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 0
Sven Mahner
University Hospital
Career Start Year 2002
Number of shared co-authors 0
Jes??s Garc??a-Donas
HM Hospitales-Centro Integral Oncologico Clara Campal
Career Start Year 2001
Number of shared co-authors 0
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 1
Douglas A Levine
Perlmutter Cancer Center
Career Start Year 1999
Number of shared co-authors 1
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Isabelle Ray-Coquard
University Claude Bernard Lyon I
Career Start Year 1997
Number of shared co-authors 0
Kathleen M Schmeler
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Kevin Holcomb
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 0
Alison Brand
Westmead Hospital
Career Start Year 1995
Number of shared co-authors 0
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 1
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 0
Rosalind Glasspool
University of Glasgow
Career Start Year 1992
Number of shared co-authors 0
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 0
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 0
Val??rie Laurence
Institut Curie
Career Start Year 1990
Number of shared co-authors 0
Fr??d??ric Amant
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 0
Paul Harnett
Westmead Clinical School, University of Sydney
Career Start Year 1986
Number of shared co-authors 0
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 3
Gottfried E Konecny
David Geffen School of Medicine at University of California Los Angeles
Career Start Year 1984
Number of shared co-authors 0
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Career Start Year 1981
Number of shared co-authors 2

Collaborators

Simone Maistro
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Co-authored papers 7
Maria Aparecida Azevedo Koike Folgueira
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
Co-authored papers 7
Giselly Encinas
Faculdade de Medicina, Universidade de Sao Paulo
Co-authored papers 4
Maria Lucia Hirata Katayama
School of Medicine of Sao Paulo University
Co-authored papers 4
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Co-authored papers 3
Ana Carolina Ribeiro Chaves de Gouv??a
Hospital Alemao Oswaldo Cruz
Co-authored papers 3
Dirce Maria Carraro
AC Camargo Cancer Center
Co-authored papers 2
F??tima Solange Pasini
Sao Paulo University
Co-authored papers 2
Gl??ucia Fernanda de Lima Pereira
Co-authored papers 2
Kathryn J Ruddy
Mayo Clinic
Co-authored papers 1
Jo??o Carlos Sampaio G??es
Brazilian Institute of Cancer Control (IBCC)
Co-authored papers 1
L??via Munhoz Rodrigues
Co-authored papers 1
Edward Chow
University of Toronto
Co-authored papers 1
Kevin Punie
Leuven Cancer Institute and University Hospitals Leuven
Co-authored papers 1
Ricardo Alves Basso
Instituto Brasileiro de Controle do Cancer
Co-authored papers 1
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 1
Maria Mitzi Brentani
Sao Paulo University
Co-authored papers 1
Rui Manuel Reis
Co-authored papers 1
Jean-Louis Vincent
Erasme Hospital, Universite Libre de Bruxelles
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Veronica Y Sabelnykova
Ontario Institute for Cancer Research
Co-authored papers 1
Florentine S Hilbers
Netherlands Cancer Institute
Co-authored papers 1
Pedro Wilson Mompean de Vasconcellos Valle
Co-authored papers 1
Pedro Adolpho de Menezes Pacheco Serio
Co-authored papers 1
Eduardo Carneiro de Lyra
Instituto Brasileiro de Controle do Cancer
Co-authored papers 1
Release 1.2